These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20946655)

  • 1. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.
    Shrestha S; Sudenga SL; Smith JS; Bachmann LH; Wilson CM; Kempf MC
    BMC Infect Dis; 2010 Oct; 10():295. PubMed ID: 20946655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Minkoff H; Zhong Y; Burk RD; Palefsky JM; Xue X; Watts DH; Levine AM; Wright RL; Colie C; D'Souza G; Massad LS; Strickler HD
    J Infect Dis; 2010 Mar; 201(5):681-90. PubMed ID: 20105077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.
    Blitz S; Baxter J; Raboud J; Walmsley S; Rachlis A; Smaill F; Ferenczy A; Coutlée F; Hankins C; Money D;
    J Infect Dis; 2013 Aug; 208(3):454-62. PubMed ID: 23624362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
    Fife KH; Wu JW; Squires KE; Watts DH; Andersen JW; Brown DR
    J Acquir Immune Defic Syndr; 2009 Jul; 51(3):274-82. PubMed ID: 19387354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.
    Minkoff H; Ahdieh L; Massad LS; Anastos K; Watts DH; Melnick S; Muderspach L; Burk R; Palefsky J
    AIDS; 2001 Nov; 15(16):2157-64. PubMed ID: 11684935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.
    Videla S; Darwich L; Cañadas MP; Paredes R; Tarrats A; Castella E; Llatjos M; Bofill M; Clotet B; Sirera G;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):168-75. PubMed ID: 19131892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.
    Mane A; Sahasrabuddhe VV; Nirmalkar A; Risbud AR; Sahay S; Bhosale RA; Vermund SH; Mehendale SM
    J Clin Virol; 2017 Mar; 88():26-32. PubMed ID: 28152432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
    Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma viruses infection among adolescent females perinatally infected with HIV in Côte d'Ivoire.
    Tchounga B; Horo A; Boni S; Tanon A; Folquet MA; Garrigue I; Leroy V; Dabis F; Ekouevi D; Jaquet A
    Sex Transm Infect; 2021 May; 97(3):238-243. PubMed ID: 32661070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus infection in HIV-positive African women living in Europe.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
    J Int AIDS Soc; 2013 Feb; 16(1):18023. PubMed ID: 23406965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women.
    Ezechi OC; Ostergren PO; Nwaokorie FO; Ujah IA; Odberg Pettersson K
    Virol J; 2014 Jan; 11():5. PubMed ID: 24433568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of HAART on HPV-related cervical disease.
    Adler DH
    Curr HIV Res; 2010 Oct; 8(7):493-7. PubMed ID: 20946095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
    Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
    Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
    Moscicki AB; Ellenberg JH; Farhat S; Xu J
    J Infect Dis; 2004 Jul; 190(1):37-45. PubMed ID: 15195241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.
    Paramsothy P; Jamieson DJ; Heilig CM; Schuman PC; Klein RS; Shah KV; Rompalo AM; Cu-Uvin S; Duerr A
    Obstet Gynecol; 2009 Jan; 113(1):26-31. PubMed ID: 19104356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest of cytology combined with Xpert
    Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
    HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
    Heard I; Palefsky JM; Kazatchkine MD
    Antivir Ther; 2004 Feb; 9(1):13-22. PubMed ID: 15040532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
    Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
    Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy.
    Garbuglia AR; Piselli P; Lapa D; Sias C; Del Nonno F; Baiocchini A; Cimaglia C; Agresta A; Capobianchi MR
    J Clin Virol; 2012 Jun; 54(2):141-6. PubMed ID: 22437054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.